AROG PHARMACEUTICALS EUROPE LIMITED

Overview

AroG Pharmaceuticals Europe Limited is a pharmaceutical company operating in Ireland, identified by CRO number 578289. The company is actively involved in clinical research, particularly in the development of crenolanib, a potent, selective type I pan-FLT3 inhibitor aimed at treating high-risk acute myeloid leukemia (AML) in patients with NPM1m and FLT3-ITD mutations. The name suggests a focus on oncology and haematological therapies. The company highlights clinical data from over 400 patients treated, with evidence of encouraging overall survival signals and a differentiated mechanism designed to overcome resistance in post-allogeneic HSCT maintenance settings. It is currently advancing toward a pivotal registration trial and welcomes collaboration from clinical sites and investigators. The business is listed in GoldenPages with a high name-similarity match and has a dedicated website detailing its clinical evidence and scientific approach. Beyond registry-level identification, no further business details are publicly captured.

Location & registered address

3Rd Floor Kilmore House

Park Lane

Spencer Dock Dublin 1

Dublin 1

Dublin

Ireland

Industry classification

NACE Rev. 2 — 72.11

→ All NACE 72.11 companies in Ireland · In Dublin